Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Clinical trial NCT05432635 · RECRUITING

Trial details

NCT number: NCT05432635
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Mantle Cell Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Transformed Non-Hodgkin Lymphoma Transformed Non-Hodgkin Lymphoma

Start date: 2023-08-01
Primary completion: 2028-03-07
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.